Enhanced Effectivity of an ALK5-Inhibitor after Cell-Specific Delivery to Hepatic Stellate Cells in Mice with Liver Injury

• Marike Marjolijn van Beuge ,

  * E-mail: m.m.van.beuge@rug.nl

  Current address: Department of Pathology and Medical Biology, Division of Medical Biology, University Medical Center Groningen, Groningen, The Netherlands

  Affiliation Department of Pharmacokinetics, Toxicology and Targeting, University of Groningen, Groningen, The Netherlands

  ⨯
• Jai Prakash,

  Current address: Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands

  Affiliation Department of Pharmacokinetics, Toxicology and Targeting, University of Groningen, Groningen, The Netherlands

  ⨯
• Marie Lacombe,

  Affiliation Kreatech Diagnostics, Amsterdam, The Netherlands

  ⨯
• Eduard Post,

  Affiliation Department of Pharmacokinetics, Toxicology and Targeting, University of Groningen, Groningen, The Netherlands

  ⨯
• Catharina Reker-Smit,

  Affiliation Department of Pharmacokinetics, Toxicology and Targeting, University of Groningen, Groningen, The Netherlands

  ⨯
• Leonie Beljaars,

  Affiliation Department of Pharmacokinetics, Toxicology and Targeting, University of Groningen, Groningen, The Netherlands

  ⨯
• Klaas Poelstra

  Affiliation Department of Pharmacokinetics, Toxicology and Targeting, University of Groningen, Groningen, The Netherlands

  ⨯